Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.36 - $0.65 $10,112 - $18,257
28,089 Added 332.06%
36,548 $13,000
Q1 2024

May 15, 2024

SELL
$0.42 - $1.38 $31,347 - $103,000
-74,638 Reduced 89.82%
8,459 $5,000
Q4 2023

Feb 15, 2024

BUY
$0.3 - $0.63 $9,869 - $20,725
32,897 Added 65.53%
83,097 $44,000
Q3 2023

Dec 19, 2023

SELL
$0.58 - $1.47 $182,508 - $462,563
-314,669 Reduced 86.24%
50,200 $30,000
Q3 2023

Nov 15, 2023

SELL
$0.58 - $1.47 $182,508 - $462,563
-314,669 Reduced 86.24%
50,200 $30,000
Q2 2023

Dec 19, 2023

BUY
$1.11 - $1.74 $117,071 - $183,517
105,470 Added 40.66%
364,869 $474,000
Q2 2023

Aug 15, 2023

BUY
$1.11 - $1.74 $117,071 - $183,517
105,470 Added 40.66%
364,869 $474,000
Q1 2023

Dec 19, 2023

BUY
$1.66 - $3.67 $13,653 - $30,185
8,225 Added 3.27%
259,399 $456,000
Q1 2023

May 15, 2023

BUY
$1.66 - $3.67 $13,653 - $30,185
8,225 Added 3.27%
259,399 $457,000
Q4 2022

Dec 19, 2023

BUY
$2.77 - $5.07 $556,697 - $1.02 Million
200,974 Added 400.35%
251,174 $788,000
Q4 2022

Feb 15, 2023

SELL
$2.77 - $5.07 $94,149 - $172,324
-33,989 Reduced 11.92%
251,174 $789,000
Q2 2022

Aug 15, 2022

BUY
$3.28 - $6.21 $354,118 - $670,450
107,963 Added 60.93%
285,163 $1.18 Million
Q4 2020

Feb 12, 2021

BUY
$9.23 - $18.18 $548,169 - $1.08 Million
59,390 Added 50.41%
177,200 $2.77 Million
Q1 2020

May 13, 2020

SELL
$5.05 - $8.85 $19,710 - $34,541
-3,903 Reduced 3.21%
117,810 $750,000
Q2 2019

Aug 12, 2019

BUY
$8.75 - $13.03 $16,520 - $24,600
1,888 Added 1.58%
121,713 $1.31 Million
Q1 2019

May 15, 2019

BUY
$7.72 - $12.81 $136,065 - $225,776
17,625 Added 17.25%
119,825 $1.14 Million
Q3 2018

Nov 14, 2018

SELL
$13.05 - $19.05 $244,948 - $357,568
-18,770 Reduced 15.52%
102,200 $1.73 Million
Q1 2018

May 15, 2018

SELL
$16.7 - $26.35 $6,980 - $11,014
-418 Reduced 0.34%
120,970 $2.3 Million
Q2 2017

Aug 16, 2017

BUY
N/A
121,388
121,388 $1.07 Million

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $193M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.